GlaxoSmithKline has spent 20 years trying to develop an improved vaccine for tuberculosis, and new data for its lead candidate M72/AS01E suggests it is getting closer to a breakthrough in the disease.

If effective, it could potentially become the first new vaccine for preventing pulmonary TB, an active form of the disease, in more than 100 years.

Thiago Silva discusses making tactical decisions for Fluminense, the form of Fabio and Jhon Arias, and a FIFA Club World Cup quarter-final against Al Hilal.

She was starting a club, she explained, to put the world on notice about how little she and any woman in her situation did ...

At present, there is only one version of the Mind 2S available, and that features an Intel Core Ultra 7 255H CPU with a 5.1 ...

A video falsely portraying Professor Salim Abdool Karim criticising Covid-19 vaccines has been denounced as disinformation. The Centre for the AIDS Programme of Research in South Africa and the ...

Eligible groups include people aged 65 and older, indigenous people aged 55 to 64, residents and staff at nursing homes and long-term care facilities, pregnant women, healthcare and disease prevention ...

Francois Venter, a big rock climber, once drank tequila with the PhD-holding virologist rockstar Dexter Holland of The ...

Francois Venter talks about his unorthodox inaugural lecture, his work during the Aids crisis and his shoot-from-the-hip fix ...

The move will likely solidify the foundation’s outsized role in global health, particularly as the United States, the United ...

New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

Early enrolment completion in the global M72 Phase 3 TB vaccine trial marks a significant milestone, with Durban sites ...